Excess Mortality Methodology reports. Folow the link to download our reports for the US and UK.
Excess Mortality Analysis for the UK. Follow the links to visualise our interactive analysis.
UK - Yearly Analysis UK - Quarterly Analysis UK - Weekly AnalysisExcess Mortality Analysis for European Countries. Follow the links to visualise our interactive analysis.
Europe - Yearly Analysis Europe - Quarterly Analysis Europe - Weekly AnalysisExcess Mortality Analysis for the USA. Follow the links to visualise our interactive analysis.
USA - Yearly Analysis USA - Quarterly Analysis USA - Weekly Analysis
Excess Mortality Analysis for Germany. We decided to separate the analysis of excess mortality for Germany from the rest of Europe as its data published on Eurostat has different age groups, as well as vaccination data. Follow the links to visualise our interactive analysis.
Germany - Yearly Analysis Germany - Quarterly Analysis Germany - Weekly Analysis
Excess Mortality Analysis for Australia. Follow the links to visualise our interactive analysis.
Australia - Yearly Analysis Australia - Quarterly Analysis Australia - Weekly Analysis
Excess Mortality Analysis for Ireland. Follow the links to visualise our interactive analysis.
Analysis of the VAERS early warning system for vaccine injury. Follow the links to visualise our analysis VAERS data, with external collaboration.
The analysis of disabilities is split into 5 parts that can be read independently but are related and complement each other. Each section is written in a different web page within which at the top the user can find the links to navigate to the other sections. The 5 parts are:
Part 1 - Overview of the Data.
Go to Part 1
This part provides the overall description of the data and shows the historical time series of disability rates for different population cohorts and age groups. It allows us to put in perspective the changes in disability rates, that started in 2021.
Part 2 - Rise in disabilities from 2021.
Go to Part 2
This part provides a detailed examination of the changes in disabilities that ocurred from early 2021, which coincided with the vaccine rollouts.
Part 3 - Relationship with Vaccine uptake.
Go to Part 3
This part analyses the relationship between the rise in disabilities with the Covid-19 vaccine rollout.
Part 4 - Relationship with Excess Deaths.
Go to Part 4
This part investigates the relationship between excess mortality and the rise in disabilities that ocurred since early 2021. It also provides us with an estimate of how many disabilities occurred for each excess death, during the period.
Part 5 - Relationship with SAEs in mRNA clinical trials
Under Construction...
This part investigates the relationship between Severe Adverse Events (SAEs) from the mRNA clinical trials with the rise in disabilities that ocurred since early 2021.
This project comprises of the review of the peer reviewed paper, published in Vaccine Journal on 9/2022, thst investigates the Serious Adverse Events (SAE) in the Pfizer and Moderna clinical trials prior to the unblinding of the participants.
Our review of the paper is important to the context of our V-Damage project as it establishes a direct link between our analysis of disabilities (using the BLS data) and the original phase III clinical trials for the Covid-19 mRNA vaccines.
Analysis of the VSAFE database for monitoring Covid-19 vaccine events. Follow the links to visualise our analysis VSAFE data, with external collaboration.
PHINANCE TECHNOLOGIES